We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 4.50 | 0.28% | 1,640.50 | 1,640.00 | 1,640.50 | 1,656.00 | 1,635.00 | 1,642.00 | 5,918,777 | 16:29:57 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.71 | 67.54B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 0117X
GlaxoSmithKline PLC
15 February 2017
GlaxoSmithKline plc (the 'Company')
Conditional Share Awards and Shares withheld or sold to meet tax liabilities
This notification sets out the details of the vesting of awards and the sale or withholding of shares to meet tax liabilities over Ordinary Shares and American Depositary Shares made in 2014 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group. The restricted period for the 2014 SVP awards has now ended and the awards made to Persons Discharging Managerial Responsibility (PDMRs) and a person closely associated with them (PCA) vested on 13 February 2017.
Transaction notification
Hot Features
Premium
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Mr L Debruyne
=== ======================== ===========================================
b) Position/status President, Global Vaccines
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the The vesting and release of Ordinary Shares
transaction awarded in 2014 under the Company's 2009
Share Value Plan.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP15.8281 6,652
------------ ----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2017-02-13
=== ======================== ===========================================
f) Place of the n/a
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Mrs V A Whyte
=== ======================== ===========================================
b) Position/status Company Secretary
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the The vesting and release of Ordinary Shares
transaction awarded in 2014 under the Company's 2009
Share Value Plan.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP15.8281 10,050
------------ ----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2017-02-13
=== ======================== ===========================================
f) Place of the n/a
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ========================================================================
a) Name Mrs V A Whyte
=== ======================== ==============================================
b) Position/status Company Secretary
=== ======================== ==============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ==============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ==============================================
b) Nature of the The sale of Ordinary Shares to meet tax
transaction liabilities further to the vesting and
release of the 2014 award under the Company's
2009 Share Value Plan.
=== ======================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ------------ ----------
GBP15.8281 4,725
------------ ----------
=== ======================== ==============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ==============================================
e) Date of the transaction 2017-02-13
=== ======================== ==============================================
f) Place of the n/a
transaction
=== ======================== ==============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================
a) Name Dr K Slaoui
=== ======================== =========================================
b) Position/status PCA of Dr M M Slaoui (Chairman, Global
Vaccines)
=== ======================== =========================================
c) Initial notification/ Initial notification
amendment
=== ======================== =========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================
a) Name GlaxoSmithKline plc
=== ======================== =========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== =========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================
a) Description of GlaxoSmithKline plc American Depositary
the financial Shares ('ADSs')
instrument ISIN: US37733W1053
=== ======================== =========================================
b) Nature of the The vesting of ADSs awarded in 2014 under
transaction the Company's 2009 Share Value Plan, of
which 822 ADSs were withheld to meet tax
liabilities.
=== ======================== =========================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$40.28 2,300
--------- ----------
=== ======================== =========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== =========================================
e) Date of the transaction 2017-02-13
=== ======================== =========================================
f) Place of the n/a
transaction
=== ======================== =========================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDELFFDLFFBBZ
(END) Dow Jones Newswires
February 15, 2017 12:15 ET (17:15 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
